But not just that, to be able to show them how to present and brand themselves better so they become highly sought-after for endorsements and sponsorships well into their professional future
SELECT-SWITCH Study Design Intro: 12-week, randomized, double blind, head-to-head (H2H), Phase 3b/4 study that evaluated the efficacy and safety of RINVOQ (upadacitinib) + MTX versus HUMIRA (adalimumab) + MTX in 491 adult patients with moderate to severe RA who demonstrated prior failure to one non-adalimumab TNF inhibitor
The same is true for smokers
The companies and opportunities are there, he said
Gunnell D, Fernando R, Hewagama M, Priyangika WD, Konradsen F, Eddleston M